Transdermal Drug Delivery System Market Scope And Analysis

Report Code : TIPRE00002894
Category : Medical Device

Status : Published
No. of Pages : 233

Buy Now

Transdermal Drug Delivery System Market Scope and Key Players Analysis by 2031

Buy Now

Transdermal Drug Delivery System Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 37,230.28 Million
Market Size by 2030	US$ 51,949.74 Million
Global CAGR (2022 - 2030)	4.3%
Historical Data	2020-2021
Forecast period	2022-2030
Segments Covered	By Type Transdermal Patches Transdermal Gel Transdermal Sprays By Application Cardiovascular Diseases Central Nervous System Disorders Pain Management Hormonal Applications Other Applications By Distribution Channel Hospitals Pharmacies Retail Phamacies Online Pharmacies
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Novartis AG GSK Plc Viatris Inc Boehringer Ingelheim International GmbH Lavipharm SA Hisamitsu Pharmaceutical Co Inc Johnson Johnson Luye Pharma Group Ltd Purdue Pharma LP

Transdermal Drug Delivery System Market News and Recent Developments

The Transdermal Drug Delivery System Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the transdermal drug delivery system market are listed below:

Starton Therapeutics Inc. has filed provisional patent applications with the U.S. Patent and Trademark Office (USPTO) for unique and novel approaches to incorporate various active pharmaceutical ingredients (APIs) into transdermal drug delivery systems, where such APIs have typically been difficult to incorporate in a transdermal drug delivery system platform. (Source: Starton Therapeutics, Company Website, January 2024)
Satio has received a $3.5 million Small Business Innovation Research (SBIR) contract from Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services. This SatioRx device is designed to be compact and inexpensive, with disposable microneedle components that allow healthcare providers to remotely deliver a precise metered dose of any liquid drug approved for transdermal delivery by the FDA. Under this contract, Satio will leverage design features from its other patch-based devices and feasibility data from its manually operated transdermal delivery devices to develop the next-generation remotely controllable device. (Source: Satio, Company Website, September 2023)

Transdermal Drug Delivery System Market Report Coverage and Deliverables

The “Transdermal Drug Delivery System Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Transdermal drug delivery system market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Transdermal drug delivery system market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Transdermal drug delivery system market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the transdermal drug delivery system market
Detailed company profiles